Skip to main content
Home
866.776.5907
Glassdoor link
Linkedin link
Twitter link
Youtube link
  • Diagnostic Services
    • New Tests
    • Test Methodologies
      • Cytogenetics
      • FISH
      • Flow Cytometry
      • IHC & ISH
      • Molecular
    • Specialty Testing
      • Hematopathology
        • Overview
        • COMPASS®
      • Solid Tumors
        • Overview
        • CancerTYPE ID®
      • NeoTYPE® Cancer Profiles
        • Overview
        • NeoTYPE® Cancer-Specific Profiles
        • NeoTYPE® Broad Reach Tumor Profiles
      • Liquid Biopsy Testing
      • NeoLAB® Liquid Biopsy
        • NeoLAB® Solid Tumor
        • NeoLAB® Heme
      • NCI-MATCH
      • Pediatric Oncology
      • Hereditary Cancer
    • Test Spotlight
    • Tech-Only Program
      • Overview
      • Virtual HemeFISH®
    • Laboratory Collaboration
    • Sponsored Testing Program
    • Get Started with NeoGenomics
  • Pharma Services
    • Pharma Services
      • Overview
      • Ordering Logistics
      • Quality and Compliance
    • Why Choose NeoGenomics
      • Overview
      • Global Capabilties
      • Expertise
    • Lab Services
      • Overview
      • Anatomic Pathology
      • MultiOmyx™
        • Overview
        • Technologies
          • Hyperplexed Immunofluorescence Assay
          • IF + DNA FISH + NGS
          • IF + RNAScope Assay
          • IF Assay + NGS from ROI
          • Protein IF & DNA FISH
        • Comprehensive Biomarker Profiling
        • Applications
          • Expression of PD-L1
          • HBV Infection
          • Profile Signaling Pathways
          • Tumor Infiltrating Lymphocyte Panel
        • Advanced Data Analysis
        • Immune Cells
        • Poster Download
        • FAQs
      • Flow Cytometry
      • FISH
      • Cytogenetics
      • Molecular
        • Overview
        • Regulated Sequencing
        • Sanger Sequencing
        • Viral Genotyping
        • Bioinformatics Services
        • Microbial Identification
        • NanoString Services
          • Overview
          • nCounter PanCancer Immune Profiling Panel
        • Next-Generation Sequencing Services
          • Overview
          • Whole Exome Sequencing
          • DNA Hybridization Capture Target Enrichment
          • PCR-based Target Enrichment
          • RNA Sequencing (RNA-Seq)
        • qPCR Services
    • CDx Services
      • Overview
      • CDx Development
      • Our Team
      • Assay Development and Validation
      • Technology Platforms and Partners
      • Regulatory and Useful Links
      • Commercialization
    • IVD Services
    • Oncology Data Services
      • Overview
      • Request More Information
    • Transfer and Validate Biomarker Assays
    • Request More Information
  • Test Menu
  • Client Services
    • Test Ordering & Pickup
      • Overview
      • Forms and Kits
      • Specimen Pick-Up
      • Online Ordering
    • Education
      • Blog: Powering Precision
      • NeoUniversity™
      • Publications, Abstracts, and Posters
      • On-Demand Webinars
    • Billing
      • Client Billing
      • Patient Billing
      • Third Party Billing
      • Prior Authorization
  • Company
    • Overview
    • Leadership
      • Leadership Team
      • Board of Directors
      • Medical and Scientific Team
      • Scientific Advisory Board
    • Careers
      • Overview
      • Benefits
    • Events
    • Investors
    • Newsletter
    • Press Releases
    • Regulatory
    • Corporate Stewardship
    • Contact Us
  • NEOLINK ® LOG IN
866.776.5907
Search Form Mobile Toggle
Mobile Menu Toggle

MultiOmyx: Expression of PD-L1

Request More Information

Sidebar Sitemap Menu

  • Pharma Services
    • Overview
    • Ordering Logistics
    • Quality and Compliance
  • Why Choose NeoGenomics
    • Overview
    • Global Capabilties
    • Expertise
  • Lab Services
    • Overview
    • Anatomic Pathology
    • MultiOmyx™
      • Overview
      • Technologies
        • Hyperplexed Immunofluorescence Assay
        • IF + DNA FISH + NGS
        • IF + RNAScope Assay
        • IF Assay + NGS from ROI
        • Protein IF & DNA FISH
      • Comprehensive Biomarker Profiling
      • Applications
        • Expression of PD-L1
        • HBV Infection
        • Profile Signaling Pathways
        • Tumor Infiltrating Lymphocyte Panel
      • Advanced Data Analysis
      • Immune Cells
      • Poster Download
      • FAQs
    • Flow Cytometry
    • FISH
    • Cytogenetics
    • Molecular
      • Overview
      • Regulated Sequencing
      • Sanger Sequencing
      • Viral Genotyping
      • Bioinformatics Services
      • Microbial Identification
      • NanoString Services
        • Overview
        • nCounter PanCancer Immune Profiling Panel
      • Next-Generation Sequencing Services
        • Overview
        • Whole Exome Sequencing
        • DNA Hybridization Capture Target Enrichment
        • PCR-based Target Enrichment
        • RNA Sequencing (RNA-Seq)
      • qPCR Services
  • CDx Services
    • Overview
    • CDx Development
    • Our Team
    • Assay Development and Validation
    • Technology Platforms and Partners
    • Regulatory and Useful Links
    • Commercialization
  • IVD Services
  • Oncology Data Services
    • Overview
    • Request More Information
  • Transfer and Validate Biomarker Assays
  • Request More Information
Expression of PD-L1 in Metastatic Breast Adenocarcinoma
Expression of PD-L1 in Metastatic Breast Adenocarcinoma
Expression of PD-L1 in Metastatic Breast Adenocarcinoma
Expression of PD-L1 in Metastatic Breast Adenocarcinoma
Expression of PD-L1 in Metastatic Breast Adenocarcinoma
Expression of PD-L1 in Metastatic Breast Adenocarcinoma
Image
NeoGenomics White Logo

12701 Commonwealth Dr., Suite 9
Fort Myers, FL 33913
T: 239.768.0600
F: 239.690.4237

Glassdoor link
Linkedin link
Twitter link
Youtube link
Image
CAP logo
Image
CLIA logo

Resources

  • Contact Us
  • Careers
  • Corporate Stewardship
  • Licensing
  • Terms
  • Privacy
  • Do Not Sell My Personal Information

More From Neo

  • Blog: Powering Precision
  • Precision Medicine in the COVID-19 Crisis
  • Sponsored Testing Program
  • PIK3CA Mutation CDx
  • NTRK Gene Fusion Testing
  • Thyroid Cancer Testing Program
  • InVisionFirst®-Lung

Sign Up

Receive weekly updates on NeoGenomics tests, research, events, and publications.

© 2020 NeoGenomics Laboratories, Inc.

Close Menu

Sitemap Menu

  • Diagnostic Services
    • New Tests
    • Test Methodologies
      • Cytogenetics
      • FISH
      • Flow Cytometry
      • IHC & ISH
      • Molecular
    • Specialty Testing
      • Hematopathology
        • Overview
        • COMPASS®
      • Solid Tumors
        • Overview
        • CancerTYPE ID®
      • NeoTYPE® Cancer Profiles
        • Overview
        • NeoTYPE® Cancer-Specific Profiles
        • NeoTYPE® Broad Reach Tumor Profiles
      • Liquid Biopsy Testing
      • NeoLAB® Liquid Biopsy
        • NeoLAB® Solid Tumor
        • NeoLAB® Heme
      • NCI-MATCH
      • Pediatric Oncology
      • Hereditary Cancer
    • Test Spotlight
    • Tech-Only Program
      • Overview
      • Virtual HemeFISH®
    • Laboratory Collaboration
    • Sponsored Testing Program
    • Get Started with NeoGenomics
  • Pharma Services
    • Pharma Services
      • Overview
      • Ordering Logistics
      • Quality and Compliance
    • Why Choose NeoGenomics
      • Overview
      • Global Capabilties
      • Expertise
    • Lab Services
      • Overview
      • Anatomic Pathology
      • MultiOmyx™
        • Overview
        • Technologies
          • Hyperplexed Immunofluorescence Assay
          • IF + DNA FISH + NGS
          • IF + RNAScope Assay
          • IF Assay + NGS from ROI
          • Protein IF & DNA FISH
        • Comprehensive Biomarker Profiling
        • Applications
          • Expression of PD-L1
          • HBV Infection
          • Profile Signaling Pathways
          • Tumor Infiltrating Lymphocyte Panel
        • Advanced Data Analysis
        • Immune Cells
        • Poster Download
        • FAQs
      • Flow Cytometry
      • FISH
      • Cytogenetics
      • Molecular
        • Overview
        • Regulated Sequencing
        • Sanger Sequencing
        • Viral Genotyping
        • Bioinformatics Services
        • Microbial Identification
        • NanoString Services
          • Overview
          • nCounter PanCancer Immune Profiling Panel
        • Next-Generation Sequencing Services
          • Overview
          • Whole Exome Sequencing
          • DNA Hybridization Capture Target Enrichment
          • PCR-based Target Enrichment
          • RNA Sequencing (RNA-Seq)
        • qPCR Services
    • CDx Services
      • Overview
      • CDx Development
      • Our Team
      • Assay Development and Validation
      • Technology Platforms and Partners
      • Regulatory and Useful Links
      • Commercialization
    • IVD Services
    • Oncology Data Services
      • Overview
      • Request More Information
    • Transfer and Validate Biomarker Assays
    • Request More Information
  • Test Menu
  • Client Services
    • Test Ordering & Pickup
      • Overview
      • Forms and Kits
      • Specimen Pick-Up
      • Online Ordering
    • Education
      • Blog: Powering Precision
      • NeoUniversity™
      • Publications, Abstracts, and Posters
      • On-Demand Webinars
    • Billing
      • Client Billing
      • Patient Billing
      • Third Party Billing
      • Prior Authorization
  • Company
    • Overview
    • Leadership
      • Leadership Team
      • Board of Directors
      • Medical and Scientific Team
      • Scientific Advisory Board
    • Careers
      • Overview
      • Benefits
    • Events
    • Investors
    • Newsletter
    • Press Releases
    • Regulatory
    • Corporate Stewardship
    • Contact Us
  • NEOLINK ® LOG IN
sfy39587stp16